Minnesota/Midwest AACE 9th Annual Meeting

BLOOMINGTON, MN US
September 22, 2018

Welcome, and thank you for attending the Minnesota/Midwest-AACE 9th Annual Meeting.

The Minnesota/Midwest Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

http://syllabus.aace.com/2018/Chapters/Minnesota-Midwest/index.html

Target Audience

Endocrinologists, MDs / Dos, advanced practice clinicians and other healthcare professionals interested in the treatment of endocrine disease living or working in Iowa, Minnesota, North Dakota, South Dakota and Wisconsin.

Learning Objectives

  1. Describe long-term trial results with denosumab
  2. Discuss possible consequences of discontinuing denosumab treatment
  3. Appraise newly approved and investigational anabolic agents
  4. Evolution of bariatric surgery
  5. Bariatric Surgery for T2DM
  6. Understanding the sleeve gastrectomy and its mechanism of action
  7. Articulate the change in understanding regarding the underlying explanation for transgender identity
  8. Outline transgender hormone strategies
  9. Consider transgender hormone monitoring strategies
  10. Evaluate indications for molecular marker use for thyroid nodules
  11. Selection of molecular markers to use for thyroid nodules
  12. Optimal management of thyroid nodule based on molecular marker testing
Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Course summary
Available credit: 
  • 4.00 AMA
  • 4.00 Attendance
Course opens: 
09/22/2018
Course expires: 
09/22/2019
Event starts: 
09/22/2018 - 7:00am
Event ends: 
09/22/2018 - 1:30pm
Cost:
$0.00

Saturday, September 22, 2018

7:00 – 7:50 AM

Registration / Breakfast

7:50 – 8:00 AM

Introductions / Overview

8:00 – 9:00 AM

Treating Osteoporosis in 2018: What's old, what's new, what's unproven, and what's true
Nelson B. Watts, MD, FACP, CCD, MACE
Objectives

  1. Describe long-term trial results with denosumab
  2. Discuss possible consequences of discontinuing denosumab treatment
  3. Appraise newly approved and investigational anabolic agents

9:00 – 10:00 AM

Weight Loss Techniques and their Metabolic Impact
Sayeed Ikramuddin, MD
Objectives

  1. Evolution of bariatric surgery
  2. Bariatric Surgery for T2DM
  3. Understanding the sleeve gastrectomy and its mechanism of action

10:00 – 10:45 AM

Break & Fellow Poster Presentations

10:45 – 11:45 AM

Transgender Medicine
Joshua Safer, MD, FACP
Objectives

  1. Articulate the change in understanding regarding the underlying explanation for transgender identity
  2. Outline transgender hormone strategies
  3. Consider transgender hormone monitoring strategies

11:45 – 12:45 PM

Molecular Markers for Thyroid Nodules and Surgical Implications
Electron Kebebew, MD
Objectives

  1. Evaluate indications for molecular marker use for thyroid nodules
  2. Selection of molecular markers to use for thyroid nodules
  3. Optimal management of thyroid nodule based on molecular marker testing

12:45 – 1:30 PM

Lunch / Fellow Award Presentation / Business Meeting

HILTON MINNEAPOLIS/BLOOMINGTON
3900 AMERICAN BLVD WEST
BLOOMINGTON, MN 55437
United States

Sayeed Ikramuddin, MD, MHA
Interim Chair and Professor
Department of Surgery
University of Minnesota Medical School
Minneapolis, MN

Electron Kebebew, MD
Professor of Surgery
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Chief, Division of General Surgery
Stanford, CA

Joshua D. Safer, MD, FACP
Executive Director
Center for Transgender Medicine and Surgery
The Mount Sinai Hospital and the Icahn School of Medicine at Mount Sinai
New York, NY

Nelson B. Watts, MD, FACP, MACE, CCD
Director
Mercy Health Osteoporosis and Bone Health Services
Cincinnati, OH

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Minnesota/Midwest Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 4.00 AMA
  • 4.00 Attendance

Accreditation Period

Course opens: 
09/22/2018
Course expires: 
09/22/2019

Price

Cost:
$0.00
Please login or register to take this course.